ZIG
BIIB icon

Zullo Investment Group’s Biogen BIIB Stock Holding History

Zullo Investment Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-301
Closed -$83.4K – 192
2022
Q4 		$83.4K Hold
301
– – 0.05% 218
2022
Q3 		$80K Hold
301
– – 0.05% 219
2022
Q2 		$61K Sell
301
-89
-23% -$18.2K 0.04% 260
2022
Q1 		$82K Sell
390
-8
-2% -$1.74K 0.04% 245
2021
Q4 		$95K Buy
+398
New +$102K 0.05% 230

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Zullo Investment Group's BIIB Position: Q1 2023 in Review

Zullo Investment Group sold out of Biogen (BIIB) in Q1 2023, closing a stake of 301 shares — an estimated $83.4K sold.

Zullo Investment Group first reported a position in BIIB in Q4 2021 and held it in 5 quarters. The position peaked at $95K in Q4 2021. 1,001 funds tracked by Wall St. Rank hold BIIB as of Q1 2023.

  • Zullo Investment Group reported no remaining Biogen position as of Q1 2023 after selling out during the quarter.
  • Zullo Investment Group sold 301 Biogen shares in Q1 2023, an estimated $83.4K.
  • Zullo Investment Group first reported a position in Biogen in Q4 2021 and held it in 5 quarters.
  • Zullo Investment Group's Biogen position peaked at $95K in Q4 2021.
  • 1,001 funds tracked by Wall St. Rank held Biogen as of Q1 2023.

Based on Zullo Investment Group's 13F filing for Q1 2023, filed 25 Apr 2023.